Search Results 3491-3500 of 34837 for oral

  1. A Study to Evaluate Lamprene (Clofazimine) to Treat Non-Tuberculous Mycobacterial (NTM) Infections - Mayo Clinic

    ... oral or injected or implanted hormonal contraception or intra-uterine device or with spermicidal foam/gel/film/ cream/vaginal suppository;; Use of oral ...

  2. A Study to Evaluate Clazakizumab in Patients with Life-threatening COVID-19 Infection (Enrolling by Invitation Only) - Mayo Clinic

    ... (oral, intravaginal, or transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); ...

  3. Dr. Adrian Vella Archives - Mayo Clinic News Network

    acarbose). Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists ...

  4. Alex G. Boutselis, M.D. - Doctors and Medical Staff - Mayo Clinic

    Awards and honors. 2024. ASER Magna Cum Laude Oral PresentationAmerican Society of Emergency Radiology Annual Meeting. 2024. 2nd Place Oral PresentationIU ...

  5. Jennifer L. Leiting, M.D. - Doctors and Medical Staff - Mayo Clinic

    Commission on Cancer Oral Presentation WinderMinnesota Surgical Society. 2018. Balfour Research Symposium Oral Presentation WinnerMayo Clinic. 2014. Alpha Omega ...

  6. Small bowel cancer - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  7. Cromolyn (inhalation route) - Side effects & dosage - Mayo Clinic

    Cromolyn oral inhalation is used to help prevent symptoms of asthma or bronchospasm (wheezing or difficulty in breathing). Cromolyn will not relieve an ...

  8. Small bowel cancer - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  9. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    Patients who have had at least two recurrences after a primary episode and have completed at least two rounds of standard-of-care oral antibiotic therapy or ...

  10. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Participation eligibility · Inadequate response to or failure to tolerate current treatment with oral corticosteroids or immunomodulators (6-mercaptopurine [6-MP] ...